Modeling fracture prediction in spinal cord injury and disease

脊髓损伤和疾病的骨折预测建模

基本信息

  • 批准号:
    8396325
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-12-01 至 2014-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Anticipated Impacts on Veteran's Healthcare: The purpose of this project is to create a working tool to estimate fracture risk in Veterans with SCI/D. This tool will help guide clinicians in decision making for which patients with SCI/D should be treated with pharmacological agents to prevent fracture. Project Background: More than 10% of all persons with a SCI/D receive care through the VA and care of Veterans with SCI/D is of central concern to the VA. We have identified that serious morbidities occur following osteoporotic fractures in Veterans with SCI/D. However, there is very little known concerning risk factors for osteoporotic fractures in SCI/D. A better understanding of risk factors for fractures in SCI/D would allow appropriate targeting of existing treatments for osteoporosis. Recently, serious side effects from pharmacological therapies for osteoporosis including osteonecrosis of the jaw and atypical femoral fractures have been reported. Thus, it has now become critically important to avoid overtreatment of patients at low risk for fracture. Tools which incorporate clinical factors and bone mineral density (BMD) measurements to estimate fracture risk have recently been developed for persons without SCI/D. However, since the pathophysiology of bone loss following SCI/D differs substantially from that of age related, postmenopausal, or even simple disuse osteoporosis, there is a need to develop a distinct model to predict fractures in SCI/D. As a first step towards developing a working model to predict fractures in SCI/D, it is critical to determine whether Dual Energy X-ray Absorptiometry (DXA)-derived BMD is indeed useful for predicting fractures. A second step in developing a working model to predict fractures in SCI/D is to determine which clinical risk factors can predict incident fractures. A final model that clearly and easily identifes which patients with SCI/D are at highest risk for fracture that can be used directly in the clinics would facilitate decision making for clinicians. Such a tool could avoid overtreatment and potential harm to those at low risk for fracture by treatments for osteoporosis, and confer the benefits of such treatments to those who are most likely to fracture. In this context, our working hypothesis is that clinical factors but not DXA-derived BMD will best predict fractures in persons with SCI/D. Our hypothesis will be examined in the following specific objectives. Specific Objective 1: Determine the utility of DXA to predict fractures in Veterans with SCI/D. We hypothesize that DXA-derived BMD will not be able to predict incident fractures in SCI/D. To test our hypothesis, using a retrospective cohort design, we will include Veterans in the SCD Registry in FY2002-2012 and determine whether DXA-derived BMD is able to predict incident fractures during the study period. Specific Objective 2: Determine the best model for non-axial fracture prediction in Veterans with SCI/D. We hypothesize that a set of clinical factors will predict incident fractures in SCI/D. To test our hypothesis, in a retrospective cohort design, we will include Veterans in the SCD Registry in FY2002-2012 and determine which clinical factors can predict risk for incident non-axial fractures through FY2012. Our final fracture prediction model will include BMD (only if BMD can predict fractures) and those clinical risk factors identified to predict incident fractures. The immediate objectives of this research are to determine whether DXA-derived BMD is a useful tool in predicting fractures in SCI/D and to develop a model to predict fractures in SCI/D. The long-term objectives are to use this model to guide treatment decisions for fracture prevention in persons with SCI/D. Project Methods: This project will utilize administrative datasets and chart review data. The resources at the VA including the VA Spinal Cord Disorders (SCD) Registry, the DSS Pharmacy and Radiology Systems, the Corporate Data Warehouse and the Austin National Patient Care Databases will provide the administrative data for this project.
描述(由申请人提供): 对退伍军人医疗保健的预期影响:本项目的目的是创建一个工作工具来估计SCI/D退伍军人的骨折风险。该工具将有助于指导临床医生决定哪些SCI/D患者应接受药物治疗以预防骨折。项目背景:超过10%的SCI/D患者通过VA接受护理,SCI/D退伍军人的护理是VA的核心问题。我们已经发现,严重的发病率发生在脊髓损伤/脊髓损伤的退伍军人骨折。然而,关于SCI/D患者发生椎体骨折的危险因素知之甚少。更好地了解SCI/D骨折的危险因素将使现有的骨质疏松症治疗方法具有适当的针对性。最近,骨质疏松症药物治疗的严重副作用,包括颌骨骨坏死和非典型股骨骨折的报道。因此,避免对骨折风险低的患者进行过度治疗变得至关重要。 最近针对无SCI/D的人开发了结合临床因素和骨矿物质密度(BMD)测量来估计骨折风险的工具。然而,由于SCI/D后骨丢失的病理生理学与年龄相关的、绝经后的、甚至简单的废用性骨质疏松症的病理生理学有很大不同,因此需要开发一种不同的模型来预测SCI/D中的骨折。作为开发预测SCI/D骨折的工作模型的第一步,确定双能X射线吸收测定法(DXA)衍生的BMD是否确实可用于预测骨折至关重要。开发预测SCI/D骨折的工作模型的第二步是确定哪些临床风险因素可以预测偶发骨折。一个最终的模型,明确和容易地确定哪些SCI/D患者骨折的风险最高,可以直接在诊所使用,将有助于临床医生的决策。这种工具可以避免过度治疗和骨质疏松症治疗对骨折风险低的人的潜在伤害,并将这种治疗的好处赋予那些最有可能骨折的人。在这种情况下,我们的工作假设是临床因素,而不是DXA衍生的BMD将最好地预测SCI/D患者的骨折。我们的假设将在以下具体目标中进行检验。具体目标1:确定DXA预测SCI/D退伍军人骨折的实用性。我们假设DXA衍生的BMD不能预测SCI/D中的骨折事件。为了验证我们的假设,我们将使用回顾性队列设计,在2002 -2012财年的SCD登记研究中纳入退伍军人,并确定DXA衍生的BMD是否能够预测研究期间发生的骨折。具体目标2:确定预测SCI/D退伍军人非轴性骨折的最佳模型。我们假设一组临床因素可以预测SCI/D中的骨折事件。为了检验我们的假设,在回顾性队列设计中,我们将纳入2002 -2012财年SCD登记研究中的退伍军人,并确定哪些临床因素可以预测2012财年发生非轴向骨折的风险。我们最终的骨折预测模型将包括BMD(仅当BMD可以预测骨折时)和那些确定用于预测偶发骨折的临床风险因素。本研究的直接目标是确定DXA衍生的BMD是否是预测SCI/D骨折的有用工具,并建立预测SCI/D骨折的模型。长期目标是使用该模型指导SCI/D患者预防骨折的治疗决策。项目方法:本项目将利用管理数据集和图表审查数据。VA的资源,包括VA脊髓疾病(SCD)登记处、DSS药房和放射学系统、企业数据仓库和奥斯汀国家患者护理数据库,将为本项目提供管理数据。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LAURA D CARBONE其他文献

LAURA D CARBONE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LAURA D CARBONE', 18)}}的其他基金

Calculator for Length of Use of Bisphosphonates (CLUB)
双膦酸盐使用期限计算器 (CLUB)
  • 批准号:
    10515879
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Calculator for Length of Use of Bisphosphonates (CLUB)
双膦酸盐使用期限计算器 (CLUB)
  • 批准号:
    10700142
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Best Practices for Management of Fractures in Spinal Cord Injuries and Disorders
脊髓损伤和疾病骨折管理的最佳实践
  • 批准号:
    9293507
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
Best Practices for Management of Fractures in Spinal Cord Injuries and Disorders
脊髓损伤和疾病骨折管理的最佳实践
  • 批准号:
    10179490
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
Best Practices for Management of Fractures in Spinal Cord Injuries and Disorders
脊髓损伤和疾病骨折管理的最佳实践
  • 批准号:
    10178106
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
THE EFFECTS OF ATKINS VS TRADITIONAL DIET ON BONE
阿特金斯饮食与传统饮食对骨骼的影响
  • 批准号:
    7375442
  • 财政年份:
    2005
  • 资助金额:
    --
  • 项目类别:
EFFICACY OF TERIPARATIDE TREATMENT OF REDUCED BMD IN LIVER TRANSPLANT PATIENTS
特立帕肽治疗肝移植患者骨密度降低的疗效
  • 批准号:
    7375430
  • 财政年份:
    2005
  • 资助金额:
    --
  • 项目类别:
EFFICACY OF TERIPARATIDE TREATMENT OF REDUCED BMD IN LIVER TRANSPLANT PATIENTS
特立帕肽治疗肝移植患者骨密度降低的疗效
  • 批准号:
    7206684
  • 财政年份:
    2004
  • 资助金额:
    --
  • 项目类别:
EFFECTS OF SODIUM ON BONE METABOLISM
钠对骨代谢的影响
  • 批准号:
    7206660
  • 财政年份:
    2004
  • 资助金额:
    --
  • 项目类别:
PAMIDRONATE INHIBITION OF SCLERODERMA FIBROBLAST PROGENITORS
帕米膦酸钠对硬皮病成纤维细胞祖细胞的抑制作用
  • 批准号:
    7206681
  • 财政年份:
    2004
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
  • 批准号:
    23K15383
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
  • 批准号:
    23H03556
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
  • 批准号:
    22H03519
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
  • 批准号:
    563657-2021
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10521849
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10671022
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
  • 批准号:
    10670918
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
  • 批准号:
    RGPIN-2018-04753
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了